Skip to main content
Log in

ASO Visual Abstract: Tumor Regression Grade and Overall Survival Following Gastrectomy with Preoperative Therapy for Gastric Cancer

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew J. Sinnamon MD, MSCE.

Ethics declarations

Disclosures

Rutika Mehta: consulting for Eli Lilly and Astellas, advisory board of Eli Lilly and Astellas, Novartis, BMS, Guardant Health, Boston Gene Speaker’s Bureau–Natera, and Daiichi Sankyo. This study was reviewed and approved by the Institutional Review Board at Moffitt Cancer Center. The major findings of this study have been presented as a Virtual Poster Grand Rounds Presentation at the Society of Surgical Oncology Meeting, 28 February to 3 March 2022.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sinnamon, A.J., Savoldy, M., Mehta, R. et al. ASO Visual Abstract: Tumor Regression Grade and Overall Survival Following Gastrectomy with Preoperative Therapy for Gastric Cancer. Ann Surg Oncol 30, 3592–3593 (2023). https://doi.org/10.1245/s10434-023-13247-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13247-3

Navigation